Antifungal natural products

被引:43
作者
Heard, Stephanie C. [1 ]
Wu, Guangwei [1 ,2 ,3 ]
Winter, Jaclyn M. [1 ]
机构
[1] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA
[2] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing 210037, Peoples R China
[3] Nanjing Forestry Univ, Jiangsu Key Lab Biomass Based Green Fuels & Chem, Nanjing 210037, Peoples R China
关键词
IN-VITRO ACTIVITY; FUNGAL CELL-WALL; DISCOVERY; DERIVATIVES; GENERATION; INSIGHTS; STATINS; ASP2397; CHITIN; AGENTS;
D O I
10.1016/j.copbio.2021.02.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Natural products are specialized small molecules produced in Nature and play pivotal roles in many cellular processes. These compounds possess exquisite chemical diversity and represent some of the most important pharmaceutical agents in human health care. With the rampant rise of fungal pathogens that are becoming resistant to nearly all clinically available antibiotics, there is an increased urgency to find new antifungal therapies with novel modes of action. To meet this need, we must be able to quickly identify new bioactive chemical scaffolds within complex natural extracts, determine their mechanisms of action, and generate appreciable yields for preclinical studies. In this review, we will highlight naturally derived antifungal agents of clinical importance as well as those with strong potential as leads in drug development.
引用
收藏
页码:232 / 241
页数:10
相关论文
共 63 条
  • [1] Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum
    Abe, Y
    Suzuki, T
    Ono, C
    Iwamoto, K
    Hosobuchi, M
    Yoshikawa, H
    [J]. MOLECULAR GENETICS AND GENOMICS, 2002, 267 (05) : 636 - 646
  • [2] Azole antifungals: 35 years of invasive fungal infection management
    Allen, David
    Wilson, Dustin
    Drew, Richard
    Perfect, John
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (06) : 787 - 798
  • [3] [Anonymous], HEXIMA
  • [4] In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents
    Arendrup, Maiken Cavling
    Jorgensen, Karin Meinike
    Hare, Rasmus Kroger
    Chowdhary, Anuradha
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [5] In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms
    Arendrup, Maiken Cavling
    Jensen, Rasmus Hare
    Cuenca-Estrella, Manuel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 532 - 536
  • [6] Is there a role for statins in fungal infections?
    Bergman, Peter W.
    Bjorkhem-Bergman, Linda
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (12) : 1391 - 1400
  • [7] Colistin interacts synergistically with echinocandins against Candida auris
    Bidaud, A. L.
    Djenontin, E.
    Botterel, F.
    Chowdhary, A.
    Dannaoui, E.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [8] Regulation of fungal secondary metabolism
    Brakhage, Axel A.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2013, 11 (01) : 21 - 32
  • [9] Hidden Killers: Human Fungal Infections
    Brown, Gordon D.
    Denning, David W.
    Gow, Neil A. R.
    Levitz, Stuart M.
    Netea, Mihai G.
    White, Theodore C.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (165)
  • [10] Synergy and antagonism in natural product extracts: when 1+1 does not equal 2
    Caesar, Lindsay K.
    Cech, Nadja B.
    [J]. NATURAL PRODUCT REPORTS, 2019, 36 (06) : 869 - 888